Format

Send to

Choose Destination
Expert Opin Ther Targets. 2012 Sep;16(9):933-44. doi: 10.1517/14728222.2012.710201. Epub 2012 Jul 26.

Class 3 semaphorins as a therapeutic target.

Author information

1
Yokohama City University, Graduate School of Medicine, Department of Molecular Pharmacology & Neurobiology, Japan. goshima@med.yokohama-cu.ac.jp

Abstract

INTRODUCTION:

The semaphorins were initially described as axon guidance molecules that play important roles in the development of nervous system. Recent studies suggest that semaphorins and their receptors also exert such diverse functions as immune response, control of vascular endothelial cell motility and invasion of many types of cancer cells.

AREAS COVERED:

The available results concerning application of class 3 semaphorins and their inhibitors for the treatment in animal disease models.

EXPERT OPINION:

Because semaphorins are now recognized as key players in immune, cardiovascular, bone metabolism and neurological system, semaphorins and their receptors are most promising therapeutic targets for various disease states. As semaphorins exert their diverse or even opposing activities in vivo, more elaborate studies on pathophysiology and signal transduction mechanisms of semaphorins are required.

PMID:
22834859
DOI:
10.1517/14728222.2012.710201
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center